{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:37:32Z","timestamp":1780731452367,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00404-020-05547-w","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:03:42Z","timestamp":1587571422000},"page":"1473-1477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tubal ligation during cesarean delivery and future risk for ovarian cancer: a population-based cohort study"],"prefix":"10.1007","volume":"301","author":[{"given":"Roy","family":"Kessous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Sergienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Sheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"2","key":"5547_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5547_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ygyno.2012.06.033","volume":"127","author":"C Maringe","year":"2012","unstructured":"Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L et al (2012) Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol 127(1):75\u201382","journal-title":"Gynecol Oncol"},{"issue":"24","key":"5547_CR3","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351(24):2519\u20132529","journal-title":"N Engl J Med"},{"issue":"22","key":"5547_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C et al (2011) Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 305(22):2295\u20132303","journal-title":"JAMA"},{"issue":"10022","key":"5547_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK et al (2016) Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387(10022):945\u2013956","journal-title":"Lancet"},{"issue":"1","key":"5547_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA (2017) Epidemiology of ovarian cancer: a review. Cancer Biol Med 14(1):9\u201332","journal-title":"Cancer Biol Med"},{"issue":"4","key":"5547_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00404-018-4868-4","volume":"298","author":"R Charach","year":"2018","unstructured":"Charach R, Sheiner E, Beharier O, Sergienko R, Kessous R (2018) Recurrent pregnancy loss and future risk of female malignancies. Arch Gynecol Obstet 298(4):781\u2013787","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"5547_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00404-016-4275-7","volume":"295","author":"O Fuchs","year":"2017","unstructured":"Fuchs O, Sheiner E, Meirovitz M, Davidson E, Sergienko R, Kessous R (2017) The association between a history of gestational diabetes mellitus and future risk for female malignancies. Arch Gynecol Obstet 295(3):731\u2013736","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"5547_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/CEJ.0000000000000228","volume":"26","author":"R Kessous","year":"2017","unstructured":"Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E (2017) Prepregnancy obesity: a risk factor for future development of ovarian and breast cancer. Eur J Cancer Prev 26(2):151\u2013155","journal-title":"Eur J Cancer Prev"},{"issue":"Suppl 10","key":"5547_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdt463","volume":"24","author":"RJ Kurman","year":"2013","unstructured":"Kurman RJ (2013) Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol 24(Suppl 10):16\u201321","journal-title":"Ann Oncol"},{"issue":"11","key":"5547_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","volume":"35","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Vang R, Junge J, Hannibal CG, Kjaer SK, Shih IM (2011) Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. Am J Surg Pathol 35(11):1605\u20131614","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"5547_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2559.2009.03408.x","volume":"55","author":"EA Jarboe","year":"2009","unstructured":"Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP (2009) Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 55(5):619","journal-title":"Histopathology"},{"key":"5547_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","volume":"55","author":"SH Yoon","year":"2016","unstructured":"Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ (2016) Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur J Cancer 55:38\u201346","journal-title":"Eur J Cancer"},{"issue":"4","key":"5547_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/1047-2797(94)00098-E","volume":"5","author":"DW Cramer","year":"1995","unstructured":"Cramer DW, Xu H (1995) Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol 5(4):310\u2013314","journal-title":"Ann Epidemiol"},{"issue":"6","key":"5547_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1158\/1055-9965.EPI-10-0068","volume":"19","author":"SP Pinheiro","year":"2010","unstructured":"Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ et al (2010) Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies. Cancer Epidemiol Biomark Prev 19(6):1595\u20131601","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5547_CR16","first-page":"1","volume":"287","author":"JA Martin","year":"2017","unstructured":"Martin JA, Hamilton BE, Osterman MJK (2017) Births in the United States, 2016. NCHS Data Brief 287:1\u20138","journal-title":"NCHS Data Brief"},{"issue":"2","key":"5547_CR17","doi-asserted-by":"publisher","first-page":"e0148343","DOI":"10.1371\/journal.pone.0148343","volume":"11","author":"AP Betr\u00e1n","year":"2016","unstructured":"Betr\u00e1n AP, Ye J, Moller AB, Zhang J, G\u00fclmezoglu AM, Torloni MR (2016) The increasing trend in caesarean section rates: global, regional and national estimates: 1990\u20132014. PLoS One 11(2):e0148343","journal-title":"PLoS One"},{"issue":"6","key":"5547_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.whi.2015.07.006","volume":"25","author":"G Garcia","year":"2015","unstructured":"Garcia G, Richardson DM, Gonzales KL, Cuevas AG (2015) Trends and disparities in postpartum sterilization after cesarean section, 2000 through 2008. Womens Health Issues 25(6):634\u2013640","journal-title":"Womens Health Issues"},{"issue":"1","key":"5547_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fertnstert.2010.03.029","volume":"94","author":"LM Chan","year":"2010","unstructured":"Chan LM, Westhoff CL (2010) Tubal sterilization trends in the United States. Fertil Steril 94(1):1\u20136","journal-title":"Fertil Steril"},{"key":"5547_CR20","first-page":"CD003034","volume":"8","author":"TA Lawrie","year":"2016","unstructured":"Lawrie TA, Kulier R, Nardin JM (2016) Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst Rev 8:CD003034","journal-title":"Cochrane Database Syst Rev"},{"key":"5547_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1690446","author":"M Yang","year":"2019","unstructured":"Yang M, Du Y, Hu Y (2019) Complete salpingectomy versus tubal ligation during cesarean section: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2019.1690446","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"5547_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.fertnstert.2014.03.041","volume":"102","author":"MS Rice","year":"2014","unstructured":"Rice MS, Hankinson SE, Tworoger SS (2014) Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. Fertil Steril 102(1):192\u20138.e3","journal-title":"Fertil Steril"},{"issue":"3","key":"5547_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","volume":"135","author":"CR Lessard-Anderson","year":"2014","unstructured":"Lessard-Anderson CR, Handlogten KS, Molitor RJ, Dowdy SC, Cliby WA, Weaver AL et al (2014) Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma. Gynecol Oncol 135(3):423\u2013427","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5547_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.12516","volume":"94","author":"C Madsen","year":"2015","unstructured":"Madsen C, Baandrup L, Dehlendorff C, Kjaer SK (2015) Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study. Acta Obstet Gynecol Scand 94(1):86\u201394","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"5547_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/humupd\/dmq030","volume":"17","author":"D Cibula","year":"2011","unstructured":"Cibula D, Widschwendter M, M\u00e1jek O, Dusek L (2011) Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update 17(1):55\u201367","journal-title":"Hum Reprod Update"},{"issue":"10","key":"5547_CR26","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/ijc.28249","volume":"133","author":"MS Rice","year":"2013","unstructured":"Rice MS, Murphy MA, Vitonis AF, Cramer DW, Titus LJ, Tworoger SS et al (2013) Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case\u2013Control Study. Int J Cancer 133(10):2415\u20132421","journal-title":"Int J Cancer"},{"issue":"3","key":"5547_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jmig.2017.01.001","volume":"24","author":"LK Ely","year":"2017","unstructured":"Ely LK, Truong M (2017) The role of opportunistic bilateral salpingectomy vs tubal occlusion or ligation for ovarian cancer prophylaxis. J Minim Invasive Gynecol 24(3):371\u2013378","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05547-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:32:53Z","timestamp":1619047973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05547-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["5547"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05547-w","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author R.K declares that he has no conflict of interest. Author S.R declares that he has no conflict of interest. Author S.E declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}